Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect

pr_newswire_finance · 2026-10-21

$ASM $DNA

Publication of first ever head-to-head comparison of gut microbiome changes associated with novel oral preclinical PolC (pol IIIC*) inhibitors to linezolid in a murine neutropenic thigh infection model Structural molecular modification of molecules related to ibezapolstat (IBZ) improved...

Sector coverage: Basic Materials · Other Precious Metals & Mining · Healthcare · Biotechnology

Read the original at pr_newswire_finance ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.